Pancuronium

   
Google
 
Web NewDrugInformation.com

Pancuronium


Drug - Pancuronium
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Pancuronium Bromide
Multiple ingredients are in alphabetical order.

Strength - 2MG/ML
The potency of the active ingredient(s), Pancuronium Bromide. May repeat for multiple part products.

Applicant - ELKINS SINN
The firm name holding legal responsibility for Pancuronium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 072060
The FDA assigned number to Pancuronium. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Pancuronium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 23, 1988
The date Pancuronium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Pancuronium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Pancuronium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Elkins Sinn Div Ah Robins Co Inc
The full name of the firm holding legal responsibility for the new application of Pancuronium.

Pancuronium